← Open Payments lookup

MICHAEL BOHR: Open Payments

NPI 1275082992 · MOOSIC, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,970 in 134 payments from 15 companies in 2025. Trend: 2023 $1,159 · 2024 $1,672 · 2025 $1,970

Food & beverage: $1,970
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)47$431
Otsuka America Pharmaceutical, Inc.19$422
ABBVIE INC.18$219
E.R. Squibb & Sons, L.L.C.11$169
Takeda Pharmaceuticals U.S.A., Inc.9$151
Alkermes, Inc.6$114
Lundbeck LLC6$109
Neurocrine BioSciences, Inc.3$73
Supernus Pharmaceuticals, Inc.4$71
Teva Pharmaceuticals USA, Inc.3$50

Products named: CAPLYTA, REXULTI, VRAYLAR, COBENFY, TRINTELLIX, ABILIFY MAINTENA, LYBALVI, INGREZZA.

Industry payments across PA — which companies pay providers there.